Connection

Ann Hollerbach to Antibodies, Antiphospholipid

This is a "connection" page, showing publications Ann Hollerbach has written about Antibodies, Antiphospholipid.
Connection Strength

0.698
  1. Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19. J Thromb Haemost. 2021 09; 19(9):2335-2347.
    View in: PubMed
    Score: 0.185
  2. Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis. Blood. 2019 10 03; 134(14):1119-1131.
    View in: PubMed
    Score: 0.162
  3. Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors. Thromb Haemost. 2019 Jul; 119(7):1147-1153.
    View in: PubMed
    Score: 0.158
  4. Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies. Blood Adv. 2018 05 08; 2(9):979-986.
    View in: PubMed
    Score: 0.148
  5. Lipid presentation by the protein C receptor links coagulation with autoimmunity. Science. 2021 03 12; 371(6534).
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.